Failure to thrive is a common manifestation of human immunodeficiency virus (
HIV) infection in children. Given the role of
insulin-like growth factor I (
IGF-I) in stimulating postnatal growth, we have examined whether HIV-infected pediatric patients with growth failure have lower serum concentrations of
IGF-I than age-matched control subjects.
IGF-I was measured in 16 HIV-infected children and 13 HIV-negative controls. Ten of the HIV-infected children failed to thrive based on height and linear growth that was below the National Center for Health Statistics 10th percentile.
IGF-I levels were significantly lower in children who failed to thrive compared to those in age-matched controls (20 vs. 60 micrograms/L; P < 0.001). Children who failed to thrive also displayed lower
IGF-I levels than HIV-positive children, who exhibited normal growth velocity (20 vs. 91 micrograms/L; P < 0.001).
Failure to thrive was associated with a significant reduction in circulating levels of IGF-binding protein-3 (IGFBP-3), as determined by
ligand and Western blotting (P < 0.001), enhanced
IGFBP-3 proteolysis (P < 0.001), and a decrease in the serum concentration of the
acid-labile subunit of the
IGFBP-3 ternary complex (P < 0.005).
IGFBP-3 proteolysis was negatively correlated with
IGF-I (r = 0.78) and
IGFBP-3 levels (r = 0.70).
Failure to thrive was associated with a reduction in the formation of the ternary complex, but the ternary complex could be restored by the addition of an excess of
IGFBP-3 to serum. These results indicate that low levels of
IGF-I,
IGFBP-3, and
acid-labile subunit are associated with a
failure to thrive in HIV-infected children.